Douglas Rashad Robinson

US Patent:

8492328, Jul 23, 2013

Filed:

May 15, 2008

Appl. No.:

12/600504

Inventors:

Fei Huang - Princeton NJ, US
Xia Han - Pennington NJ, US
Rameh Hafezi - Franklin Park NJ, US
Jiwen Chen - Bridgewater NJ, US
Douglas Michael Robinson - Hanover MA, US
Gayle M. Wittenberg - Princeton NJ, US
Ashok Ramesh Dongre - Newtown PA, US
Joan M. Carboni - Yardley PA, US
Ricardo M. Attar - Lawrenceville NJ, US
Warren Hurlburt - Mount Laurel NJ, US
Marco M. Gottardis - Princeton NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A01N 61/00
G01N 33/53

US Classification:

514 1, 435 71

Abstract:

IGF1R biomarkers useful in a method for identifying and monitoring a mammal that will respond therapeutically to a method of treating cancer comprising administering an IGF1R modulator, wherein the method comprises (a) exposing the mammal to the IGF1R modulator and (b) measuring in the mammal the level of the at least one biomarker, wherein a difference in the level of the at least one biomarker measured in (b) compared to the level of the biomarker in a mammal that has not been exposed to the IGF1R modulator indicates that the mammal will respond therapeutically to the method of treating cancer and (c) wherein the level of the biomarker in a mammal after exposure to a IGF1R modulator indicates that the mammal has responded therapeutically to the method of treating cancer.

US Patent:

20110269139, Nov 3, 2011

Filed:

Jan 6, 2010

Appl. No.:

13/143228

Inventors:

Ji Gao - Cranbury NJ, US
Gayle M. Wittenberg - Plainsboro NJ, US
Douglas Michael Robinson - Hanover MA, US
Ashok Ramesh Dongre - Newtown PA, US

International Classification:

C12Q 1/68
C12Q 1/02
G01N 21/64
G01N 33/559
G01N 30/02
G01N 21/55
G01N 27/26
G01N 33/566
H01J 49/26

US Classification:

435 612, 435 721, 435 71, 435 792, 435 29, 436501, 250282, 73 6152, 356445, 204450, 204456

Abstract:

The present invention provides methods useful for predicting the likelihood that a mammal that will respond therapeutically to a method of treating cancer comprising administering an EGFR modulator, and diagnostic methods and kits thereof.

US Patent:

20180146448, May 24, 2018

Filed:

Nov 28, 2017

Appl. No.:

15/824635

Inventors:

- New York NY, US
Douglas Eugene Robinson - New York NY, US

Assignee:

Fresh Digital, Inc. - New York NY

International Classification:

H04W 64/00
G01S 5/02
B64C 39/02
G01S 1/02

Abstract:

Venue information is stored, the venue information including a first location portion of the venue and a second location portion of the venue. An actual presence of a location sensing mobile device is identified within the venue, the actual presence identified based on beacon signals received from a beacon associated with the first location portion of the venue. A first drone associated with the first location portion of the venue is selected based on the actual presence. First sensor data is received from the first drone. A virtual presence of the location sensing mobile device is received, the virtual presence being different from the actual presence. A second drone associated with the second location portion of the venue is selected based on the virtual presence. Second sensor data is received from the second drone. The first and second sensor data is transmitted to the location sensing mobile device.